Predictive ability of a semi-mechanistic model for neutropenia in the development of novel anti-cancer agents: two case studies

Predictive ability of a semi-mechanistic model for neutropenia in the development of novel anti-cancer agents: two case studies

In cancer chemotherapy neutropenia is a common dose-limiting toxicity. An ability to predict the neutropenic effects of cytotoxic agents based on proposed trial designs and models conditioned on previous studies would be valuable. The aim of this study was to evaluate the ability of a semi-mechanist...

Full description

Bibliographic Details
Main Authors: Soto, Elena, Keizer, Ron J., Trocóniz, Iñaki F., Huitema, Alwin D. R., Beijnen, Jos H., Schellens, Jan H. M., Wanders, Jantien, Cendrós, Josep María, Obach, Rosendo, Peraire, Concepción, Friberg, Lena E., Karlsson, Mats O.
Format: Online
Language:English
Published: Springer US 2010
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160557/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160557/

Similar Items